XRONIK KUNDALIK BOSH OG‘RIQLARINI SHAXSIYLASHTIRILGAN DAVOLASH: GENETIK VA QON TOMIR MARKERLARINING AHAMIYATI

##plugins.themes.bootstrap3.article.sidebar##

PDF (Русский)
Nashr: Jild 5 Nomeri 8 : Евразийский журнал медицинских и естественных наук
Bo'lim: Статьи
##semicolon##
##submission.license.cc.by4.footer##

##plugins.themes.bootstrap3.article.main##

PhD. Central Asian University, Ташкент, Узбекистан Университетская клиника Akfamedline, Ташкент, Узбекистан
dr.kadyrkhodjayeva@gmail.com
Центр сенсорной интеграции и развития речи, Ташкент, Узбекистан. Доктор медицинских наук.
dr.kadyrkhodjayeva@gmail.com

Abstrak:

Ushbu maqolada xronik kundalik bosh og‘riqlarni (XKBO) davolashda shaxsiylashtirilgan yondashuvning ahamiyati yoritilgan. Asosiy e’tibor kasallik patogenezida genetik va tomir markerlarining ta’siriga hamda davolash samaradorligiga qaratilgan. Genetik omillar bosh og‘riqlarining individual xususiyatlarini belgilashda va organizmning dori vositalariga javobini prognoz qilishda muhim rol o‘ynaydi. Tomir markerlari esa miyada qon aylanishi va trofika o‘zgarishlarini baholash imkonini beradi. Ilmiy tahlil natijalari shuni ko‘rsatadiki, shaxsiylashtirilgan terapiyadan foydalanish davolash samaradorligini oshirishi, nojo‘ya ta’sirlarni kamaytirishi va bemorning hayot sifatini yaxshilashi mumkin.

##semicolon##

##plugins.themes.bootstrap3.article.details##

##submission.howToCite##:

Кадырходжаева , Н. ., & Прохорова , А. . (2025). XRONIK KUNDALIK BOSH OG‘RIQLARINI SHAXSIYLASHTIRILGAN DAVOLASH: GENETIK VA QON TOMIR MARKERLARINING AHAMIYATI. Yevrosiyo Tibbiyot Va Tabiiy Fanlar Jurnali Universal Indeks Kutubxonasi, 5(8), 56–59. Retrieved from https://lib.uniconflix.com/index.php/UILEJMNS/article/view/58666

##submission.citations##:

Diener HC, Solbach K, Holle D, Gaul C. Medication-overuse headache: risk factors, pathophysiology and management. Nat Rev Neurol. 2016;12(10):575-583.

Jiménez-Sánchez L, et al. Role of homocysteine in migraine: pathways, genes and pharmacogenetics. Pharmacol Res. 2021;167:105576.

Kowa H, et al. The influence of MTHFR gene polymorphism on the efficacy of triptans in migraine attacks. Neurology. 2012;78(7):544-547.

Ke X, et al. The link between hyperhomocysteinemia and vascular cognitive impairment: A meta-analysis. Neurosci Biobehav Rev. 2021;126:146-158.

Bockowski L, Sobaniec W, Kulak W. Plasma homocysteine and B vitamins in children with migraine. Headache. 2005;45(4):346-352.